PRINCY PAUL: Open Payments
NPI 1013501980 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 24 payments from 11 companies in 2025. Trend: 2023 $1,922 · 2024 $445 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 9 | $239 |
| Collegium Pharmaceutical, Inc. | 5 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Amgen Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
| Radius Health, Inc. | 1 | $21 |
| Biogen, Inc. | 1 | $20 |
| Neurelis, Inc. | 1 | $18 |
| SCILEX PHARMACEUTICALS INC. | 1 | $15 |
Products named: INCEPTIV, Belbuca, RELISTOR, UPLIZNA, INGREZZA, XTAMPZA, UBRELVY, Tymlos.
Industry payments across NC — which companies pay providers there.
